BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17189396)

  • 21. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
    Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
    Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.
    Meche A; Cîmpean AM; Raica M
    Rom J Morphol Embryol; 2009; 50(2):217-21. PubMed ID: 19434314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.
    Cho KS; Lee JS; Cho NH; Park K; Ham WS; Choi YD
    Prostate; 2008 Jun; 68(8):803-8. PubMed ID: 18302229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.
    Franco-Hernandez C; Martinez-Glez V; Arjona D; de Campos JM; Isla A; Gutierrez M; Vaquero J; Rey JA
    Cancer Genet Cytogenet; 2007 Feb; 173(1):63-7. PubMed ID: 17284372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
    Tran N; Bharaj BS; Diamandis EP; Smith M; Li BD; Yu H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2133-40. PubMed ID: 15598771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
    Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
    J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
    Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
    Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of EGFR genetic variants on glioma risk and patient outcome.
    Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of EGFR gene transcription by a polymorphic repetitive sequence--a link between genetics and epigenetics.
    Gebhardt F; Bürger H; Brandt B
    Int J Biol Markers; 2000; 15(1):105-10. PubMed ID: 10763151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.
    Tsuge M; Hamamoto R; Silva FP; Ohnishi Y; Chayama K; Kamatani N; Furukawa Y; Nakamura Y
    Nat Genet; 2005 Oct; 37(10):1104-7. PubMed ID: 16155568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
    Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
    Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
    Kharrat N; Al'Fadhli S; Rebaï A
    J Recept Signal Transduct Res; 2008; 28(5):475-83. PubMed ID: 18946768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissues.
    Zhou Q; Cheung YB; Jada SR; Lim WT; Kuo WL; Gray JW; Lee AS; Chowbay B
    Cancer Biol Ther; 2006 Nov; 5(11):1445-9. PubMed ID: 17102595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene.
    Brandt B; Hermann S; Straif K; Tidow N; Buerger H; Chang-Claude J
    Cancer Res; 2004 Jan; 64(1):7-12. PubMed ID: 14729599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
    Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
    BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.